Modified amino acid derivatives for treatment of neurological diseases and selected psychiatric disorders

摘要

The notified product is a derivative of 2-(2,5-dioxopyrrolidin-1-yl)propanamide with a stereogenic centre configuration selected from: (2R)-N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide of model 1 and (2R)-2-(2,5-dioxopyrrolidin-1-yl)-N-(2-fluorobenzyl)propanamide of model 2. The notification shall also include the following: relationship in the treatment or prevention of epilepsy, epilepsy with associated depressive and anxiety disorders, depression, anxiety, neurological pain, inflammatory pain or neurodegenerative disease.